Clinical Trial Update: Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating concomitant administration of the Novavax COVID-19 vaccine with a 20-valent pneumococcal conjugate vaccine in adults aged 60 and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• 20-valent pneumococcal conjugate vaccine (pneumococcal conjugate vaccine, 20-valent)
• Novavax vaccine

Snippet

Sponsor: Medical University of Vienna | Conditions: COVID-19, Pneumococcal Infections | Phase 4 | Status: UNKNOWN